Targeting Innate Immunity to Treat Cancer

por Austin, Matthew, Kluger, Harriet
Publicado 2020

Systemic Immunotherapy for the Treatment of Brain Metastases

por Cohen, Justine V., Kluger, Harriet M.
Publicado 2016

CheckMate-915: does adjuvant CTLA-4 blockade play a role in resected melanoma?

por Su, David, Kluger, Harriet, Weiss, Sarah A.
Publicado 2023

Drug targets and predictive biomarkers in the management of metastatic melanoma

por Thumar, Jaykumar, Giesen, Eva, Kluger, Harriet M
Publicado 2012

Anti-PD-1 Therapy-Associated Perforating Colitis

por Celli, Romulo, Kluger, Harriet M., Zhang, Xuchen
Publicado 2018

Agonistic CD40 Antibodies in Cancer Treatment

por Djureinovic, Dijana, Wang, Meina, Kluger, Harriet M.
Publicado 2021

SIMVI reveals intrinsic and spatial-induced states in spatial omics data

por Dong, Mingze, Kluger, Harriet, Fan, Rong, Kluger, Yuval
Publicado 2023

Characterizing disease states from topological properties of transcriptional regulatory networks

por Tuck, David P, Kluger, Harriet M, Kluger, Yuval
Publicado 2006

Cardiac Biventricular Metastasis From Renal Cell Carcinoma

por Latifi, Ahmad Nawid, Ibe, Uzochukwu, Arbune, Amit, Kluger, Harriet, Baldassarre, Lauren A
Publicado 2020

MEK targeting in N-RAS mutated metastatic melanoma

por Thumar, Jaykumar, Shahbazian, David, Aziz, Saadia A, Jilaveanu, Lucia B, Kluger, Harriet M
Publicado 2014

Case report: Metastatic Merkel cell carcinoma presenting seven years after loco-regional disease resection of primary tumor with interval in-transit and nodal metastases

por Rusheen, Joshua, Clune, James, Ariyan, Stephan, Baumann, Raymond, Kluger, Harriet, Olino, Kelly, Weiss, Sarah
Publicado 2023

Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy

por Martinez-Morilla, Sandra, Zugazagoitia, Jon, Wong, Pok Fai, Kluger, Harriet M., Rimm, David L.
Publicado 2020

Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma

por Su, David, Djureinovic, Dijana, Schoenfeld, David, Marquez-Nostra, Bernadette, Olino, Kelly, Jilaveanu, Lucia, Kluger, Harriet
Publicado 2023

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma

por Giesen, Eva, Jilaveanu, Lucia B., Parisi, Fabio, Kluger, Yuval, Camp, Robert L., Kluger, Harriet M.
Publicado 2014

Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy

por Hughes, Jing, Vudattu, Nalini, Sznol, Mario, Gettinger, Scott, Kluger, Harriet, Lupsa, Beatrice, Herold, Kevan C.
Publicado 2015

A modified IL-18 drug in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma

por Schoenfeld, David, Djureinovic, Dijana, Zhang, Lin, Mann, Jacqueline, Huck, John, Jilaveanu, Lucia, Ring, Aaron, Kluger, Harriet
Publicado 2023

Vascularity of primary and metastatic renal cell carcinoma specimens

por Aziz, Saadia A, Sznol, Joshua, Adeniran, Adebowale, Colberg, John W, Camp, Robert L, Kluger, Harriet M
Publicado 2013

MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors

por Shuch, Brian, Falbo, Ryan, Parisi, Fabio, Adeniran, Adebowale, Kluger, Yuval, Kluger, Harriet M., Jilaveanu, Lucia B.
Publicado 2015

Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer

por Dhodapkar, Kavita, Verma, Rakesh, Sznol, Mario, Boddupalli, Chandra Sekhar, Gettinger, Scott, Kluger, Harriet, Dhodapkar, Madhav, Das, Rituparna
Publicado 2014

Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer

por Nadler, Yasmine, Camp, Robert L, Giltnane, Jennifer M, Moeder, Christopher, Rimm, David L, Kluger, Harriet M, Kluger, Yuval
Publicado 2008